Robustly, FOXD1, but not FOXD2, FOXD3 and FOXD4, was significantly (p < 0.01) upregulated in primary tumors compared to normal adjacent tissues derived from oral cancer patients deposited in the GSE42743 dataset (Figure 1D). This evidence concerns the gene FOXD2 and lip and oral cavity carcinoma.